Arkolith/Insider Trading/AYTU/Form 4

Pyszczymuka Greg

Chief Commerical OfficerAYTU BIOPHARMA, INC (AYTU) · full profile →Form 4 · filed Jun 20, 2023
Net Buying
Open-Market Buys
$22K
Open-Market Sells
$0
Net Open-Market Flow
$22K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 16, 2023Buy(P)12K$1.87$22K22K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000912282-23-000137) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for AYTU BIOPHARMA, INC

Build

Ask your agent about AYTU insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Get a key Compare plansForm 4 data
Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0000912282-23-000137"
Ask your agent
Use Arkolith to summarize insider buying and selling at AYTU BIOPHARMA, INC
over the last 90 days and cite the filings.